Investment
Quantinuum's $300m round shows growing corporate bets on quantum
Backed by JPMorgan Chase, Honeywell, Amgen, Mitsui & Co, Quantinuum is working both on quantum hardware and software — and is now one of the biggest players in the field.
Spinout tracker: January 2024
GUV is launching a weekly spinout tracker to surface the most exciting new and emerging companies based on university research.
GV makes another bet on CRISPR with Moonwalk investment
GV backs another spinout by MIT’s serial entrepreneur Feng Zhang as epigenetics becomes an emerging area of healthcare.
University spinouts doubled fundraising in the last decade
Countries like Germany, Switzerland and Japan have benefitted from an explosive growth in capital, but the US still dominates and the UK risks being left behind, our in-depth analysis shows.
Cleerly captures investors’ hearts in $192m series C
Launched just a year ago to build on work at Weill Cornell Medicine and New York-Presbyterian Hospital, Cleerly has now closed an oversubscribed series C round.
CardiaTec captures $1.7m
Cambridge Enterprise has put cash into CardiaTec Biosciences in a pre-seed round that marks the inaugural deal for Laidlaw Scholars Ventures.
OQC heads to Japan after $46m series A
Oxford Quantum Circuits' series A round is already among the largest for a European quantum company and could still go higher.
ReCode registers $120m series B extension
UT Southwestern Medical Center spinout ReCode Therapeutics has now raised a total of $200m in its series B round from investors including Osage University Partners.
Other News
Zap Energy zips to $160m series C
University of Washington spinout Zap Energy is working on building a cheap, scalable fusion reactor generating low cost and carbon free energy.
MicroTransponder manifests $53m series E
Osage University Partners has added MicroTransponder to a small but mightly portfolio of medical device companies.
Elypta elicits $21m series A
Chalmers spinout Elypta is working on a metabolism-based liquid biopsy for early cancer detection that it hopes will catch any type of the disease.
Deals: June 1, 2022
Orphan CNS therapy developer Minoryx Therapeutics closed a $54.8m series C and MIT's The Engine co-led a $10.5m seed round for Foundation Alloy.
Deals: May 31, 2022
ZGT has raised $48m from Tsinghua Holdings Capital, CAS Star and others, while University of Cambridge spinout Colorifix has pocketed $22.7m.
Deals: May 27, 2022
The Global University Venturing deal net rounds up the smaller investments from across the university innovation ecosystem.
Editor's Picks
Sony and Intel back company making key part for next wave of…
UK smartphone camera component developer Cambridge Mechatronics’ latest round featured strategic investors Sony Ventures and Intel Capital.
Spike in AI deals and exits for corporate investors
Corporate investors have been part of $3bn worth of AI deals so far this year, with June particularly strong. There has also been a uptick in exits.
The corporate bull case for real estate
Corporates continued to invest in real estate tech through 2022, unlike their traditional VC peers. We look at how this might play out.